{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:47:54Z","timestamp":1771472874427,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/gco.0b013e3283577e9d","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T17:24:48Z","timestamp":1345310688000},"page":"299-304","source":"Crossref","is-referenced-by-count":10,"title":["Expedited partner therapy for sexually transmitted infections"],"prefix":"10.1097","volume":"24","author":[{"given":"Matthew","family":"Hogben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gale R.","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2105\/AJPH.93.6.882","article-title":"Field-delivered therapy increases treatment for chlamydia and gonorrhea.","volume":"93","author":"Steiner","year":"2003","journal-title":"Am J Public Health"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11908-010-0159-3","article-title":"Expedited partner therapy for sexually transmitted infections: an update.","volume":"13","author":"Kissinger","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007435-200301000-00011","article-title":"Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women.","volume":"30","author":"Schillinger","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Impact of expedited sex partner treatment on recurrent or persistent gonorrhea or chlamydial infection: a randomized controlled trial.","volume":"352","author":"Golden","year":"2005","journal-title":"New Engl J Med"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/432476","article-title":"Patient-delivered partner treatment for male urethritis: a randomized controlled trial.","volume":"41","author":"Kissinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/bmj.39079.460741.7C","article-title":"Improved effectiveness of partner notification for patients with sexually transmitted infections: Systematic review.","volume":"334","author":"Trelle","year":"2007","journal-title":"BMJ"},{"key":"R8-7-20210129","first-page":"1","article-title":"Sexually Transmitted Disease treatment guidelines, 2010.","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/humrep\/den475","article-title":"Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.","volume":"24","author":"Cameron","year":"2009","journal-title":"Hum Reprod"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1136\/sti.2010.047670","article-title":"Barriers to the implementation of expedited partner therapy.","volume":"87","author":"Golden","year":"2011","journal-title":"Sex Transm Inf"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/sti.2010.047258","article-title":"Can we improve partner notification rates through expedited partner therapy in the UK Findings from an exploratory trial of Accelerated Partner Therapy (APT).","volume":"88","author":"Estcourt","year":"2012","journal-title":"Sex Transm Inf"},{"key":"R12-7-20210129","first-page":"17","article-title":"Is Accelerated Partner Therapy partner notification for sexually transmissible infections acceptable and feasible in general practice Sex H","volume":"8","author":"Shackleton","year":"2011","journal-title":"ealth"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/OLQ.0b013e31822e9192","article-title":"The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea.","volume":"38","author":"Gift","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/OLQ.0b013e3181dd1691","article-title":"A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.","volume":"37","author":"Schwebke","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/OLQ.0b013e3182240366","article-title":"Chlamydia partner services for females in California family planning clinics.","volume":"38","author":"Yu","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/OLQ.0b013e318214bb83","article-title":"Implementation of expedited partner therapy among women with chlamydia infection at an urban family planning clinic.","volume":"38","author":"Kerns","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/OLQ.0b013e3181d8920f","article-title":"The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco.","volume":"37","author":"Stephens","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2105\/AJPH.2007.113381","article-title":"Expedited partner therapy for sexually transmitted diseases: Assessing the legal environment.","volume":"98","author":"Hodge","year":"2008","journal-title":"Am J Public Health"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1471-0528.2008.01977.x","article-title":"Preferred strategies of men and women for managing chlamydial infection.","volume":"116","author":"Melvin","year":"2009","journal-title":"Brit J Obstet Gyn"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/OLQ.0b013e31821c390b","article-title":"Partner notification of sexually transmitted diseases: Practices and preferences.","volume":"38","author":"Gursahaney","year":"2011","journal-title":"Sex Transm Dis"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/OLQ.0b013e31818eb73c","article-title":"Alternative approaches to partner notification, diagnosis, and treatment: Pharmacists perspectives on proposed patient delivered partner therapy in New York State, 2007.","volume":"36","author":"McNutt","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R23-7-20210129","first-page":"437","article-title":"Patient-delivered partner therapy in the UK: what do the professionals think Int J STD","volume":"19","author":"Shivasankar","year":"2008","journal-title":"AIDS"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1258\/ijsa.2011.010492","article-title":"Reticence to prescribe: utilization of expedited partner therapy among obstetrics providers in Arizona.","volume":"22","author":"Taylor","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/OLQ.0b013e31818eb8f8","article-title":"Alternative approaches to partner notification, diagnosis, and treatment: Perspectives of New York County health departments, 2007.","volume":"36","author":"Davis","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/AAC.48.8.3185-3187.2004","article-title":"Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones.","volume":"48","author":"Ito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s101560200011","article-title":"A remarkable reduction in the susceptibility of Neisseria gonorrhoeae isolates to cephems and the selection of antibiotic regimens for the single-dose treatment of gonococcal infection in Japan.","volume":"8","author":"Tanaka","year":"2002","journal-title":"J Infect Chemother"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/OLQ.0b013e3180ca8f24","article-title":"X, Jiang F, Quimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.","volume":"34","year":"2007","journal-title":"Sex Transm Dis"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.","volume":"36","author":"Cole","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182401b69","article-title":"Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.","volume":"39","author":"Martin","year":"2012","journal-title":"Sex Transm Dis"},{"key":"R31-7-20210129","first-page":"873","article-title":"Cephalosporin susceptibility among Neisseria gonorrhoeae isolates: United States, 2000-2010.","volume":"60","year":"2011","journal-title":"MMWR"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200mg cefixime at a 6-h interval.","volume":"9","author":"Deguchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea.","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1258\/ijsa.2009.009191","article-title":"Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations.","volume":"22","author":"Forsyth","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R39-7-20210129","first-page":"590","article-title":"Update to CDCs Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections.","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/cir929","article-title":"Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.","volume":"54","author":"Katz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jac\/dkp188","article-title":"Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales.","volume":"64","author":"Chisholm","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"suppl","key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.2105\/AJPH.2007.112128","article-title":"Reducing sexually transmitted infection rates by improving patient referral for treatment: a randomized, controlled trial.","volume":"99","author":"Wilson","year":"2009","journal-title":"Am J Public Health"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0b013e3283577e9d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:48:16Z","timestamp":1743983296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201210000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3283577e9d","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}